Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,952
Total Claims
$577K
Drug Cost
947
Beneficiaries
$609
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
-85%
Cost per patient vs peers
$609 vs $4,034 avg
-67%
Brand preference vs peers
3.1% vs 9.4% avg
Brand vs Generic
Brand: 596 claims · $100K
Generic: 18,337 claims · $476K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Memantine Hcl | 3,746 | $77K |
| Rivastigmine Tartrate | 1,062 | $64K |
| Rivastigmine | 279 | $60K |
| Galantamine Hbr | 474 | $41K |
| Galantamine Hbr | 488 | $29K |
| Donepezil Hcl | 1,101 | $23K |
| Memantine Hcl | 185 | $20K |
| Omega-3 Acid Ethyl Esters | 284 | $20K |
| Famotidine | 1,125 | $13K |
| Bupropion Hcl | 480 | $12K |
| Nimodipine | 72 | $12K |
| Carbidopa/Levodopa/Entacapone | 95 | $11K |
| Sertraline Hcl | 1,397 | $10K |
| Memantine Hcl | 18 | $8,337 |
| Selegiline Hcl | 106 | $8,043 |
Prescribing Profile
85
Unique Drugs
15.0
Anomaly Score
Patient Profile
78
Avg Age
64%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About